Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial
Guberina, M., Eberhardt, W., Stuschke, M., Gauler, T., Heinzelmann, F., Cheufou, D., Kimmich, M., Friedel, G., Schmidberger, H., Darwiche, K., Jendrossek, V., Schuler, M., Stamatis, G., Pöttgen, C.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
Joerger, M., von Pawel, J., Kraff, S., Fischer, J.R., Eberhardt, W., Gauler, T.C., Mueller, L., Reinmuth, N., Reck, M., Kimmich, M., Mayer, F., Kopp, H.-G., Behringer, D.M., Ko, Y.-D., Hilger, R.A., Roessler, M., Kloft, C., Henrich, A., Moritz, B., Miller, M.C., Salamone, S.J., Jaehde, U.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example
Griesinger, F, Radke, S, Lüers, A, Deschler-Baier, B, Kimmich, M, Sebastian, M, Schulz, C, Brugger, W, Wiewrodt, R, Pirker, R, Früh, M, Gautschi, O, Wolf, J
Published in Pneumologie (Stuttgart, Germany) (01.11.2018)
Published in Pneumologie (Stuttgart, Germany) (01.11.2018)
Get more information
Journal Article
3066 Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent: Updated results of the randomized CEPAC-TDM study
Joerger, M, Von Pawel, J, Kraff, S, Fischer, J.R, Gauler, T, Mueller, L, Reinmuth, N, Reck, M, Kimmich, M, Frank, M, Kopp, H.G, Behringer, D, Ko, Y.D, Ralf, H, Roessler, M, Kloft, C, Henrich, A, Moritz, B, Jaehde, U
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome
Falkenstern-Ge, R. F., Kimmich, M., Friedel, G., Tannapfel, A., Neumann, V., Kohlhaeufl, M.
Published in Journal of cancer research and clinical oncology (01.10.2011)
Published in Journal of cancer research and clinical oncology (01.10.2011)
Get full text
Journal Article
Pulmonary Adenocarcinoma Occurring 5 Years after Resection of a Primary Pancreatic Adenocarcinoma : A Relevant Differential Diagnosis
Falkenstern-Ge, R. F., Wohlleber, M., Kimmich, M., Huettl, K., Friedel, G., Ott, G., Kohlhäufl, M.
Published in Case reports in oncological medicine (01.01.2014)
Published in Case reports in oncological medicine (01.01.2014)
Get full text
Journal Article
Lung Metastasis of Primary Alveolar Soft-Part Sarcoma Occurring 20 Years after Initial Treatment
Kimmich, M., Falkenstern-Ge, R. F., Wohlleber, M., Grabner, A., Friedel, G., Ott, G., Leuschner, Ivo, Kohlhäufl, M.
Published in Case reports in oncological medicine (01.01.2013)
Published in Case reports in oncological medicine (01.01.2013)
Get full text
Journal Article
1442P DURATION: A multicenter randomized phase II trial investigating sequential mono- (mCTX) or doublet-chemotherapy (dCTX) followed by durvalumab (D) in older or frail patients with advanced non-small cell lung cancer (NSCLC)
Kuon, J.B., Blasi, M., Kokowski, K., Faehling, M., Schuette, W., Christoph, D.C.C., Kimmich, M., Engel-Riedel, W., Fischer, J.R., Lehmann, M., Ulmer, M., Schuett, P., Moosmann, N., Meyer zum Büschenfelde, C., Griesinger, F., Schneider, M., Behnisch, R., Stenzinger, A., Christopoulos, P., Thomas, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1021P DURATION - a phase II randomized trial in older / frail patients (pts) with advanced non-small cell lung cancer (NSCLC) comparing chemotherapy (CTX, 4 cycles) with CTX (2 cycles) and consecutive durvalumab (D): Top-line early efficacy endpoints
Kuon, J.B., Blasi, M., Kokowski, K., Faehling, M., Schuette, W., Christoph, D.C.C., Kimmich, M., Engel-Riedel, W., Fischer, J., Lehmann, M., Ulmer, M., Schuett, P., Moosmann, N., Meyer zum Bueschenfelde, C., Griesinger, F., Schneider, M., Behnisch, R., Stenzinger, A., Christopoulos, P., Thomas, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1246P Hybrid capture-based assays in primary diagnostics of NSCLC patients: Results from the NEOlung study
Jori, B., Gautschi, O., Kimmich, M., Beaucaire Danel, S., Reinmuth, N., Garrido Lopez, P., Cappuzzo, F., Forster, M., Patel, K., Grohe, C., Müller, A., Wesseler, C., Menon, R., Müller, J., Mariotti, E., Brinkmann, J., Heukamp, L., Griesinger, F.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
OA02.03 Amivantamab Plus Lazertinib vs Osimertinib in First-line EGFR-mutant Advanced NSCLC: Longer Follow-up of the MARIPOSA Study
Gadgeel, S., Cho, B.C., Lu, S., Felip, E., Hayashi, H., Spira, A.I., Besse, B., Thomas, M., Owen, S., Kim, Y.J., Lee, S.-H., Mourão Dias, J., Lee, Y.-G., Zhao, Y., Fang, Y., Girard, N., Liu, Z., Sun, P., Oliveira, S.C. Sousa, Shen, H., Paz-Ares, L., Matsumoto, S., Tanaka, H., Ahmad, A.R., Andabekov, T., Sunpaweravong, P., Ozyilkan, O., Yang, J.C.-H., Gottfried, M., Hernandez, O., Kimmich, M., Cortinovis, D., Kaen, D.L., Montes, L.V. García, Popat, S., Newsom-Davis, T., Xie, J., Sun, T., Fennema, E., Daksh, M., Ennis, M., Sethi, S., Bauml, J.M., Nguyen, D.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
MA06.08 Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
Eberhardt, W.E.E., Poettgen, C., Gauler, T.C., Schulte, C., Friedel, G., Kopp, H.-G., Fischer, B., Schmidberger, H., Kimmich, M., Budach, W., Cordes, S., Metzenmacher, M., de Los Rios, R. Hepp, Spengler, W., De Ruysscher, D., Belka, C., Welter, S., Brintrup, D. Luetke, Guberina, M., Oezkan, F., Darwiche, K., Schuler, M., Jöckel, K.-H., Aigner, C., Stamatis, G., Stuschke, M.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
Schumann, Christian, Sebastian, Martin, Sadjadian, Parvis, Märten, Angela, Abdollahi, A., Aries, S.P., Arntzen, C., Atmaca, A., Basara, N., Borchard, B., Bos, M., Brugger, W., Budweiser, S., Corduan, K., Cortes‐Incio, D., Dallmeier, B., Denzlinger, C., Dittrich, I., Engel‐Riedel, W., Faehling, M., Fertl, A., Fischer, J.R., Fleckenstein, D., Folprecht, G., Forstbauer, A., France, Y., Frickhofen, N., Gardizi, M., Gauler, T., Gessner, C., Gökkurt, E., Görner, M., Grah, C., Greeve, J., Greiner, J., Grohé, C., Grüning, W., Guggenberger, D., Heinrich, B., Hense, G., Hoiczyk, M., Huber, R.M., Illerhaus, G., Jacobs, G., Jung, P., Kern, J., Kersten, J., Kiehl, M., Kisro, J., Knipp, H., Ko, Y.D., Koch, J.U., Koehne, C.H., Kollmeier, J., Kommer, A., Körber, W., Krause, G., Krügel, R., Leistner, R., Liebers, U., Lommatzsch, M., Maintz, C., Mohr, M., Neumeister, W., Overbeck, T., Panse, J., Pelzer, T., Peters, K., Planker, M., Reissig, A., Ritter, M., Sadjadian, P., Sandritter, B., Schatz, M., Scheffler, M., Schmid‐Bindert, G., Schneider, C.P., Schneider‐Kappus, W., Schreiber, J., Schütte, W., Schütz, S., Sebastian, M., Serke, M., Staiger, H., Stehle, I., Stengele, K., Stöhlmacher‐Williams, J., Strapatsas, T., Sulzbach, B., Tessmer, A., Thomas, M., Ukena, D., Wagner, B., Wagner‐Hug, D., Witt, C., Wohlleber, M., Wolf, J., Wricke, K., Zaba, O., Zander, I.
Published in The oncologist (Dayton, Ohio) (01.10.2015)
Published in The oncologist (Dayton, Ohio) (01.10.2015)
Get full text
Journal Article